ABVC BioPharma, Inc. (ABVC) Free cash flow 2022–2024
ABVC BioPharma, Inc. (ABVC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$1.8MFY2024 · since FY2022: -$7.4M → -$1.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$1.8M | +57.5% |
| FY2023 | -$4.3M | +41.9% |
| FY2022 | -$7.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ABVC financial trends
ABVC RevenueABVC Net incomeABVC Net marginABVC Gross profitABVC Gross marginABVC Operating incomeABVC Operating marginABVC Operating cash flowABVC Capital expendituresABVC Return on equityABVC Stock buybacksABVC Dividends paidABVC Total assetsABVC Total liabilitiesABVC Shareholders’ equityABVC overview →